Outcomes in Scleroderma-Related Interstitial Lung Disease Following Lung Transplant

被引:2
|
作者
Sottile, P. D. [1 ]
Iturbe, D. [2 ]
Golden, J. A. [3 ]
Katsumoto, T. R. [4 ]
Connolly, M. K. [5 ]
Collard, H. R. [3 ]
Hoopes, C. [6 ]
Kukreja, J. [6 ]
Leard, L. E. [3 ]
Singer, J. P. [3 ]
机构
[1] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA
[2] Hosp Univ Marques Valdecilla, Santander, Spain
[3] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Dermatol & Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Cardiothorac Surg, San Francisco, CA 94143 USA
来源
关键词
D O I
10.1016/j.healun.2011.01.622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
609
引用
收藏
页码:S204 / S204
页数:1
相关论文
共 50 条
  • [1] SURVIVAL IN SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE FOLLOWING LUNG TRANSPLANT
    Sottile, P. D.
    Iturbe, D. F.
    Katsumoto, T.
    Connolly, K. M.
    Collard, H.
    Golden, J. A.
    Hoopes, C.
    Singer, J. P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 204 - 204
  • [2] Lung Function Decline in Scleroderma-Related Interstitial Lung Disease
    Barczi, E.
    Palmer, E.
    Kolonics-Farkas, A.
    Vincze, K.
    Eszes, N.
    Bohacs, A.
    Mueller, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Scleroderma-related interstitial lung disease: principles of management
    Das, Aparna
    Kumar, Anupam
    Arrossi, Andrea Valeria
    Ghosh, Subha
    Highland, Kristin B.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (04) : 357 - 367
  • [4] Determining progression of scleroderma-related interstitial lung disease
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Kim, Grace Hyun
    Goldin, Jonathan
    Clements, Philip J.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (01) : 62 - 70
  • [5] Mycophenolate mofetil for scleroderma-related interstitial lung disease
    Zaheen, Ahmad
    Stanbrook, Matthew B.
    Anand, Anju
    LANCET RESPIRATORY MEDICINE, 2016, 4 (11): : E53 - E53
  • [6] Predicting Treatment Outcomes And Responder Subsets In Scleroderma-Related Interstitial Lung Disease
    Roth, M. D.
    Tseng, C. -H.
    Clements, P. J.
    Furst, D. E.
    Tashkin, D. P.
    Goldin, J. G.
    Khanna, D.
    Kleerup, E. C.
    Li, N.
    Elashoff, D.
    Elashoff, R. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [7] Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung Disease
    Roth, Michael D.
    Tseng, Chi-Hong
    Clements, Philip J.
    Furst, Daniel E.
    Tashkin, Donald P.
    Goldin, Jonathan G.
    Khanna, Dinesh
    Kleerup, Eric C.
    Li, Ning
    Elashoff, David
    Elashoff, Robert M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (09): : 2797 - 2808
  • [8] Lung transplantation for scleroderma-related lung disease
    Richardson, Claire B.
    Singer, Jonathan P.
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (03) : 79 - 87
  • [9] Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
    Carmen Pilar Simeón-Aznar
    Vicent Fonollosa-Plá
    Carles Tolosa-Vilella
    Albert Selva-O’Callaghan
    Roser Solans-Laqué
    Miquel Vilardell-Tarrés
    Clinical Rheumatology, 2011, 30 : 1393 - 1398
  • [10] Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
    Pilar Simeon-Aznar, Carmen
    Fonollosa-Pla, Vicent
    Tolosa-Vilella, Carles
    Selva-O'Callaghan, Albert
    Solans-Laque, Roser
    Vilardell-Tarres, Miquel
    CLINICAL RHEUMATOLOGY, 2011, 30 (11) : 1393 - 1398